Publikationen 1996

BANGER M, HIEMKE C, HAUPT M, KNUPPEN R (1996) Excretion of 2- and 3monomethyl ethers of 2-hydroxyestrogens in healthy male volunteers. Eur J Endocrinol 135: 193-197 BENKERT O, GRÜNDER G, WETZEL H, HACKETT D (1996) A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia. J Psychiatr Res 30: 441-451 BENKERT O, HIPPIUS H (1996) Psychiatrische Pharmakotherapie. Springer, Berlin. 552 Seiten BENKERT O, SZEGEDI A, WETZEL H (1996) Minimum effective dose for antidepressants - an obligatory requirement for antidepressant drug evaluation? Int Clin Psychopharmacol 11: 177-185 BURKART M, HEUN R, MAIER W (1996) Correspondence. Compr Psychiatry 37: 148-149 DAHMEN N, BIERBRAUER J, HIEMKE C (1996) Immunologie der Depression. Zeitschrift für Medizinische Psychologie: S. 94-100 DAHMEN N, FISCHER V, HÖDL P, RUJESCU D, REUSS S, BARTOSZYK GD, HIEMKE C (1996) Induction of c-fos gene expression by the selective sigma receptor ligand EMD 57445 in rat brain. Eur Neuropsychopharmacol 6: 237-243 ERDMANN J, SHIMRON-ABARBANELL D, RIETSCHEL M, ALBUS M, MAIER W, KÖRNER J, BONDY B, CHEN K, SHIH JC, KNAPP M, PROPPING P, NÖTHEN MM (1996) Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum Genet 97: 614-619 FELL J, RÖSCHKE J, GRÖZINGER M (1996) Neural net classification of REM sleep based on spectral measures as compared to nonlinear measures. In: DAGLI CH, AKAY M, CHEN CLP, FERNANDEZ BR, GHOSH J (Hrsg) Intelligent Engineering Systems through Artifical Neural Networks. ASME Press, New York. S. 671-678 FELL J, RÖSCHKE J, MANN K, SCHÄFFNER C (1996) Discrimination of sleep stages: a comparison between spectral and nonlinear EEG measures. Electroencephalogr Clin Neurophysiol 98: 401-410 FELL J, RÖSCHKE J, SCHÄFFNER C (1996) Surrogate data analysis of sleep electroencephalograms reveals evidence for nonlinearity. Biol Cybern 75: 85-92 FUCHS E, KRAMER M, HERMES B, NETTER P, HIEMKE C (1996) Psychosocial stress in tree shrews: clomipramine counteracts behavioral and endocrine changes. Pharmacol Biochem Behav 54: 219-228

GÄNSICKE M, MINGES J, FRANKE P, MAIER W (1996) Assoziation oder Dissoziation von Negativ- und Positivsymptomatik bei Risikopersonen für Schizophrenie. In: MÖLLER H-J, ENGEL RR, HOFF P (Hrsg) Befunderhebung in der Psychiatrie. Springer, Wien. S. 165-173 GERBALDO H, MÜLLER-SIECHENEDER F (1996) Über die Bedeutung der primären Negativsymptomatik bei schizophrenen und anderen psychiatrischen Patienten. Fortschr Neurol Psychiatr 64: 221-227 GRÖZINGER M, RÖSCHKE J (1996) Recognition of rapid-eye-movement sleep from single-channel EEG data by artificial neural networks: a study in depressive patients with and without amitriptyline treatment. Neuropsychobiology 33: 155-159 GRÖZINGER M, UHL T, SCHÄFFNER C, RÖSCHKE J (1996) Therapeutic rem sleep deprivation rendered possible by application of artificial neural networks to one channel eeg data. In: DAGLI CH, AKAY M, CHEN CLP, FERNANDEZ BR, GHOSH J (Hrsg) Intelligent Engineering Systems through Artifical Neural Networks. ASME Press, New York. S. 679-684 GRÜNDER G, WETZEL H, SCHLÖßER R, BENKERT O (1996) Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring. Pharmacopsychiatry 29: 72-78 HÄRTTER S, BAIER D, DINGEMANSE J, ZIEGLER G, HIEMKE C (1996) Automated determination of dextromethorphan and its main metabolites in human plasma by high-performance liquid chromatography and column switching. Ther Drug Monit 18: 297-303 HÄRTTER S, DINGEMANSE J, BAIER D, ZIEGLER G, HIEMKE C (1996) The role of cytochrome P450 2D6 in the metabolism of moclobemide. Eur Neuropsychopharmacol 6: 225-230 HEUN R, BURKART M, BENKERT O (1996) Influence of repetition and naming on picture recall and recognition in patients with dementia of Alzheimer's type. Annals of Psychiatry 6: 23-31 HEUN R, BURKART M, HELTEN E, KUNZ S, MAIER W (1996) Psychiatric disorders in relatives of patients with geriatric depression and senile dementia of the Alzheimer's type: methodological considerations. Annals of Psychiatry 6: 13-21 HEUN R, HARDT J, BURKART M, MAIER W (1996) Validity of the family history method in relatives of gerontopsychiatric patients. Psychiatry Res 62: 227-238 HEUN R, MAIER W, MÜLLER H (1996) Gender and Alzheimer’s Disease. Letter to the editor. Neurology 47: 1357-1358 HIEMKE C, STOLP M, REUSS S, WEVERS A, REINHARDT S, MAELICKE A, SCHLEGEL S, SCHRÖDER H (1996) Expression of alpha subunit genes of nicotinic acetylcholine receptors in human lymphocytes. Neurosci Lett 214: 171-174

HILLERT A, SANDMANN J, EHMIG SC, SOBOTA K, WEISBECKER W, KEPPLINGER HM, BENKERT 0 (1996) Psychopharmacological drugs as represented in the press: results of systematic analysis of newspapers and popular magazines. Pharmacopsychiatry 29: 67-71 HOPF HC, SCHLEGEL S (1996) Depression im Gefolge von Hirninfarkten. In: MÖLLER H-J, PRZUNTEK H, LAUX G, BÜTTNER T (Hrsg) Therapie im Grenzgebiet von Psychiatrie und Neurologie. Springer, Berlin. S. 117-129 KNOFLACH F, BENKE D, WANG Y, SCHEURER L, LÜDDENS H, HAMILTON BJ, CARTER DB, MOHLER H, BENSON JA (1996) Pharmacological modulation of the diazepam-insensitive recombinant g-aminobutyric acidA receptors a4b2g2 and a6b2g2. Molecular Pharmacology 50: 1253-1261 LECRUBIER Y, WEILLER E, PRIVETT M, BOYER P, MAIER W, ÜSTÜN TB, SARTORIUS N on behalf of the prinicipal investigators of the WHO International Study on Psychological Problems in General Health Care (1996) Recognition and treatment of patients with sleep problems in general health care. Eur Psychiatry 11 (Suppl 1): 11s-14s LINDEN M, MAIER W, ACHBERGER M, HERR R, HELMCHEN H, BENKERT O (1996) Psychische Erkrankungen und ihre Behandlung in Allgemeinarztpraxen in Deutschland. Nervenarzt 67: 205-215 LÜDDENS H, KORPI ER (1996) GABAA receptors: pharmacology, behavioral roles, and motor disorders. The Neuroscientist 2: 15-23 MÄKELÄ R, LEHTONEN M, WISDEN W, LÜDDENS H, KORPI ER (1996) Blunted furosemide action on cerebellar GABAA receptors in ANT rats selectively bred for high alcohol sensitivity. Neuropharmacology 35: 1493-1502 MAIER W, DELMO CD (1996) Dual diagnoses. Baillieres Clinical Psychiatry 2: 405420 MAIER W, FRANKE P, HEUN R (1996) Co-morbidity and co-segregation in psychiatric genetics. Bailleres Clinical Psychiatry 2: 83-98 MAIER W, FRANKE P, MINGES J, LICHTERMANN D, HEUN R (1996) Vulnerabilität für Schizophrenie: Entwicklung einer Modellvorstellung anhand von Familienstudien. In: MÖLLER H-J, DEISTER A (Hrsg) Vulnerabilität für affektive und schizophrene Erkrankungen. Springer, Wien. S. 77-88 MAIER W, MINGES J, ECKSTEIN N, BRODSKI C, ALBUS M, LERER B, HALLMAYER J, FIMMERS R, ACKENHEIL M, EBSTEIN RE, BORRMANN M, LICHTERMANN D, WILDENAUER DB (1996) Genetic relationship between dopamine transporter gene and schizophrenia: linkage and association. Schizophr Res 20: 175-180 MANN K, BAUER H, HIEMKE C, RÖSCHKE J, WETZTEL H, BENKERT O (1996) Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion. Eur Neuropsychopharmacol 6: 163-168

MANN K, KLINGLER T, NOE S, RÖSCHKE J, MÜLLER S, BENKERT O (1996) Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction. Arch Sex Behav 25: 1-16 MANN K, RÖSCHKE J (1996) Stimulation der Atmung im Schlaf durch KortikotropinReleasing-Hormon. In: MAYER G (Hrsg) Jahrbuch Schlafmedizin in Deutschland. MMV Medizin Verlag, München. S. 162-164 MANN K, RÖSCHKE J (1996) Effects of pulsed high-frequency electromagnetic fields on human sleep. Neuropsychobiology 33: 41-47 MANN K, RÖSCHKE J (1996) REM-Suppression unter dem Einfluß digitaler Funktelefone. Wien med Wschr WMW 146: 285-286 MANN K, RÖSCHKE J, FELL J, FRANK C, WAGNER P (1996) Sequentielle Analyse der Übertragungseigenschaften des ZNS während konsekutiver REMPerioden. Wien med Wschr WMW 146: 283-284 MAURER K, SCHLEGEL S, DIERKS T, FRÖLICH L, SCHLÖSSER R (1996) Neuroimaging in Psychiaty. In: HÄFNER H, WOLPERT EM. (Hrsg) New research in psychiatry. Hogrefe & Huber Publishers, Göttingen. S. 113-140. RIETSCHEL M, NÖTHEN MM, ALBUS M, MAIER W, MINGES J, BONDY B, KÖRNER J, HEMMER S, FIMMERS R, MÖLLER H-J, WILDENAUER D, PROPPING P (1996) Dopamine D3 receptor Gly9/Ser9 polymorphism and schizophrenia: no increased frequency of homozygosity in German familial cases. Schizophr Res 20: 181-186 RÖSCHKE J, MANN K (1996) Determiniertes Chaos und Schlaf-EEG bei Schizophrenie und Depression. In: MAYER G (Hrsg) Jahrbuch Schlafmedizin in Deutschland. MMV Medizin Verlag, München. S. 183-186 RÖSCHKE J, MANN K, WAGNER P, GRÖZINGER M, FELL J, FRANK C (1996) An approach to single trial analysis of event-related potentials based on signal detection theory. Int J Psychophysiol 22: 155-162 RÖSCHKE J, PRENTICE-CUNTZ T, WAGNER P, MANN K, FRANK C (1996) Amplitude frequency characteristics of evoked potentials during sleep: an analysis of the brain's transfer properties in depression. Biol Psychiatry 40: 736-743 RÖSCHKE J, WAGNER P, MANN K, FELL J, GRÖZINGER M, FRANK C (1996) Single trials analysis of event related potentials: a comparison between schizophrenics and depressives. Biol Psychiatry 40: 844-852 SCHLEGEL S, SCHLÖSSER R, HIEMKE C, NICKEL O, BOCKISCH A, HAHN K (1996) Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT. Psychopharmacology (Berl) 124: 285-287 SCHLEGEL S, SCHLÖßER R, NICKEL O, BOCKISCH A (1996) Rezeptordarstellung mit der Single Photonen Emissions Computertomographie (SPECT): Stand der Forschung und Perspektiven. In: MÖLLER H-J, MÜLLER-SPAHN F, KURTZ G

(Hrsg) Akutuelle Perspektien der Biologischen Psychiatrie. Springer, Wien. S. 732737 SCHLÖßER R, SCHLEGEL S, HIEMKE CH, NICKEL O, BOCKISCH A (1996) Benzodiazepinrezeptorbindung im [123I]-IOMAZENIL-SPECT in Relation zu CortisolPlasmaspiegeln. In: MÖLLER H-J, MÜLLER-SPAHN F, KURTZ G (Hrsg) Aktuelle Perspektiven der Biologischen Psychiatrie. Springer, Wien. S. 429-431 SCHLOESSER R, SIMKOWITZ P, BARTLETT EJ, WOLKIN A, SMITH GS, Dewey SL, BRODIE JD (1996) The study of Neurotransmitter interactions using positron emission tomography and functional coupling. Clin Neuropharmacol 19: 371-389 SHIMRON-ABARBANELL D, HARMS H, ERDMANN J, ALBUS M, MAIER W, RIETSCHEL M, KÖRNER J, WEIGELT B, FRANZEK E, SANDER T, KNAPP M, PROPPING P, NÖTHEN MM (1996) Systematic screening for mutations in the human serotonin 1F receptor gene in patients with bipolar affective disorder and schzizophrenia. Am J Med Genet 67: 225-228 SZEGEDI A, WETZEL H, LEAL M, HÄRTTER S, HIEMKE C (1996) Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data. J Clin Psychiatry 57: 257-264 ÜSTÜN TB, PRIVETT M, LECRUBIER Y, WEILLER E, SIMON G, KORTEN A, BASSETT SS, MAIER W, SARTORIUS N on behalf of the investigators of the WHO International Study on Psychological Problems in General Health Care (1996) Form, frequency and burden of sleep problems in general health care: a report from the WHO Collaborative Study on Psychological Problems in General Healt Care. Eur Psychiatry 11 (Suppl 1): 5s-10s WEIFFENBACH O, GÄNSICKE M, FAUST G, MAIER W (1996) Psychische und psychosomatische Störungen in der Allgemeinpraxis: Ergebnisse und Kosequenzen einer WHO-Studie. In: HELMCHEN H, HIPPIUS H (Hrsg) Psychiatrie für die Praxis 23. MMV Medizin Verlag, München. S. 48-59 WONG G, KUOPPAMÄKI M, HIETALA J, LÜDDENS H, SYVÄLAHTI E, KORPI ER (1996) Effects of clozapine metabolites and chronic clozapine treatment on rat brain GABAA receptors. Eur J Pharmacol 314: 319-323